Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (158)	9/14/1999 8:10:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 673

Thanks for pointing this out. Grrrr indeed. MedImmune (MEDI) brought out RespiGam, which prevents respiratory infections in infants. "They did $200 million in sales on this drug last year -- that's astounding," von Emster says Doesn't he mean Synagis instead of old-hat RespiGam? Such error for MEDI, his number 7 holding. Wonder how deep is his research for his minor holdings. -g- (Picky)PB

To: scaram(o)uche who wrote (158)	9/14/1999 8:23:00 PM
From: LLCF	Respond to of 673

I like this part: investors in the group have been feeling the pain. With the broad market up 8% through the middle of September, the average health-care sector mutual fund was eking out an advance of 3.3%, according to Lipper Analytical. Oh, the pain, the pain!! Please do it to me some more! more! Sorry, DAK

To: scaram(o)uche who wrote (158)	9/14/1999 8:33:00 PM
From: LLCF	Respond to of 673

Grrrrr: "We're focusing on companies in the discovery area -- companies discovering new products -- that will be the Amgens of five or 10 years from now," he says. The portfolio excludes big pharmaceutical manufacturers." What a joke... he puked 'em out about 1 year ago today... and now he's buying 'em back this year! Well thanks 100+% KvE!!! Thats about what you pissed away into many SI investors pockets... feel rest assured that the money will be well used! DAK